Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Oncology/Epidemiology
  • Published:

Clinical Oncology/Epidemiology

The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma

British Journal of Cancer volume 64, pages 379–380 (1991)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. University Hospital Nottingham, UK

    JFF Robertson

Authors
  1. JFF Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. DL Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. IO Ellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. NC Armitage
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. JD Hardcastle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robertson, J., Morris, D., Ellis, I. et al. The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma. Br J Cancer 64, 379–380 (1991). https://doi.org/10.1038/bjc.1991.312

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1991.312

Search

Advanced search

Quick links